πŸ‡ΊπŸ‡Έ FDA
Patent

US 6608060

Inhibitors of p38

expired A61PA61P1/00A61P1/04

Quick answer

US patent 6608060 (Inhibitors of p38) held by Vertex Pharmaceuticals Incorporated expires Mon Aug 14 2023 00:00:00 GMT+0000 (Coordinated Universal Time). Status: expired.

Key facts

Applicant
Vertex Pharmaceuticals Incorporated
Grant date
Tue Aug 19 2003 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Aug 14 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
27
CPC classes
A61P, A61P1/00, A61P1/04, A61P1/18, A61P11/00